Antabio
antabio.com
Actively hiring
Hospitals & Health Systems
Health Care
Infectious Disease Therapeutics
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
News
Antabio Highlights New Data on their Novel β-lactam/β-lactamase Inhibitor, Meropenem-Pilabactam (formerly Meropenem-ANT3310) at the 36th Congress of the European Society of Clinical Microbiology and Infectious Diseases
Labège, France, April 27, 2026 - Antabio, a clinical-stage biopharmaceutical company developing novel antibacterial treatments targeting drug-resistant infections identified by WHO and CDC as critical priorities, today highlighted the presentation of new
Read more
Report
Antabio and GARDP join forces to identify potential next-generation antibiotics
Geneva/Labège, 23 March 2026. The French biotech company Antabio and the GARDP Foundation (known as GARDP) today announced a joint effort to accelerate crucial early-stage antibiotic discovery, responding to a steep rise in drug-resistant infections world
Read more
Report
Antabio Announces Successful Completion of Phase 1 Clinical Study of MEM-ANT3310 for Severe Hospital Infections
Labège, France, September 3rd, 2024. Antabio, a private biopharmaceutical company developing novel and highly differentiated antibacterial treatments for critical priority pathogens, with a particular focus on life-threatening respiratory infections, toda
Read more
Report
ANTABIO Announces Appointment of Dr. Erick Lelouche as Chairman of the Board
Labège, France, March 19th 2024. Antabio SAS, a clinical stage biopharmaceutical company developing novel treatments for severe drug-resistantbacterial infections, is pleased to announce the appointment of Dr. Erick Lelouche as Chairman of the Board of Di
Read more
Report
ANTABIO Raises €25 million in Series B Financing
Antabio raises €25M in Series B financing to support Phase 2 clinical development of MEM-ANT3310 for drug-resistant infections.
Read more
Report
Pro access
Upgrade to see all 19 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
People
Marc Lemonnier
Président de SAS
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Labège
France
HQ
Contact us
50-200 est. staff
436 Rue Pierre et Marie Curie, 31670 Labège – France